Skip to content
Homepage
Clinic directory

Clinics in Houston, New York

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Houston, NY

Chelation Therapy clinics in Houston

Chelation therapy in Houston is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity. Referral and testing pathways often interact with Texas Medical Center, Memorial Hermann, Houston Methodist, and MD Anderson when lab confirmation is needed. Local demand is shaped by a large energy-industry and international patient base, and clinics vary in whether they push short detox courses or longer TACT-modeled cardiovascular protocols.

FDA-approved agents for specific poisoning diagnoses include calcium disodium EDTA, DMSA, and deferoxamine. Chelation for cardiovascular disease or autism is not FDA-approved and has caused deaths when the wrong EDTA form is used. Texas Medical Board and active compounding pharmacy ecosystem shapes which providers can deliver chelation and under what supervision.

With verified chelation clinics on Regenerated.com in Houston, Texas, patients can compare provider credentials, testing protocols, and whether the clinic uses calcium disodium EDTA (the correct form) or the dangerous disodium EDTA. ACAM-trained MDs with documented pre-treatment heavy metal testing are the minimum bar.

No clinics found

Try adjusting your filters or search terms

Reset all filters

Regulatory context

A note on New York's chelation therapy rules.

The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.

  • New York Education Law, Title VIII, Article 131 (Medicine)
    Governs MD and DO practice in New York including chelation administration.
  • New York Public Health Law Section 230
    Establishes the Office of Professional Medical Conduct which investigates physician misconduct including off-label chelation.

The New York State Office of Professional Medical Conduct (OPMC) has investigated chelation practitioners for marketing claims tied to autism and cardiovascular disease. New York does not license NDs. New York City and the surrounding areas have a large integrative medicine community. New York has historically been one of the more aggressive states on enforcement against off-label chelation marketing, particularly for pediatric autism. The 2005 Pittsburgh pediatric chelation death prompted heightened New York scrutiny.

Sources: fda.gov · health.ny.gov · pubmed.ncbi.nlm.nih.gov

Chelation Therapy in Houston, answered.

EDTA IV sessions run 150 to 400 dollars per session. DMPS and DMSA protocols, oral or IV, cost 200 to 500 dollars per session. A standard 10-session detox course runs 1,500 to 4,000 dollars. The longer 30-session TACT-style cardiovascular protocol, which is not FDA-approved, runs 4,500 to 12,000 dollars including labs and supplements. Insurance covers chelation only for confirmed lead, mercury, or iron poisoning using FDA-approved agents at appropriate facilities.

The FDA has approved calcium disodium EDTA, DMSA, and deferoxamine for specific heavy metal poisoning diagnoses, lead, mercury, iron overload. Chelation for cardiovascular disease has not been FDA-approved. The 2013 TACT trial suggested possible benefit in diabetic post-MI patients, but the FDA has not approved chelation for any cardiovascular indication. Chelation is not FDA-approved for autism, and major pediatric and autism research organizations specifically advise against it.

Providers in Houston are typically MDs or DOs with American College for Advancement in Medicine, ACAM, training. Naturopathic doctors may offer chelation within their state-specific scope, which varies significantly. Verify the provider is licensed, insured, and uses the correct EDTA form. Calcium disodium EDTA is the standard. Disodium EDTA, the wrong form, has caused fatal hypocalcemia and is specifically warned against by the FDA for chelation use.

Chelation can be dangerous if misused. In 2005, a five-year-old autistic child in Pittsburgh died from hypocalcemia after receiving the wrong EDTA form. The FDA has issued specific warnings about disodium EDTA, Na2EDTA, versus calcium disodium EDTA. Risks include electrolyte disturbance, kidney stress, and reactions to mobilized metals. Chelation for autism is not supported by evidence and is considered unsafe by pediatric authorities. Proper testing, correct agent, and monitoring reduce risk substantially.

Verify the provider is a licensed MD, DO, or in-scope ND with documented chelation training, ACAM is the most common credential. Insist on heavy metal testing before starting a protocol, ideally baseline urine or blood plus a provocation test. Confirm the clinic uses calcium disodium EDTA or appropriate agents, not disodium EDTA. Ask for realistic framing. Chelation for cardiovascular disease or autism is not FDA-approved and should include informed consent that makes the non-approval explicit.

Explore related care

Related Treatments

Treatment guide

Learn about Chelation Therapy

What it is, how it works, and what to expect.

Filters

Rating

Treatments

Advanced Therapies
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion 1
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology